STAQ Pharma, Inc.: Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV u

STAQ Pharma, Inc.: Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colora

DrugsSource: FDA (drug) · Date: 2025-10-22

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand: STAQ Pharma, Inc.
Product: Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Reason / hazard: Labeling: Incorrect or Missing Lot and/or Exp Date
Classification: Class III
Status: Ongoing
Distribution / sold at: Nationwide in the U.S.
Recall initiated: 2025-10-09
Code info: Lot #: 25104595A, Expiry: 27DEC2025.
Voluntary mandated: Voluntary: Firm initiated
City: Denver
State: CO
Country: United States
Event id: 97779